HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
171419.0,259757,2203-11-04 06:45:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
   Not putting out enough urine on Lasix drip, increased to 20mg/hr,
   increased Milrinone to 0.75mcg/kg/min and given 2 doses of diuril.
   Pacer settings changed for CHB of unknown etiology causing bradycardia.
   Now set at DDD with HR 80s.
   ROS: Pt complains of right elbow pain.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Furosemide (Lasix) - 20 mg/hour
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2203-11-4**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 35.7
C (96.3
   HR: 84 (43 - 89) bpm
   BP: 94/46(57) {89/40(52) - 119/66(77)} mmHg
   RR: 17 (10 - 31) insp/min
   SpO2: 99% on 4L
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,144 mL
                                                                    189 mL
   PO:
                                                                    750 mL
             TF:
   IVF:
                                                                    394 mL
                                                                    189 mL
   Blood products:
   Total out:
                                                                  1,365 mL
                                                                    155 mL
   Urine:
                                                                  1,165 mL
                                                                    155 mL
   NG:
                                                                    200 mL
   Stool:
   Drains:
   Balance:
                                                                   -221 mL
                                                                     34 mL
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   115 K/uL
   7.3 g/dL
   135 mg/dL
   2.7 mg/dL
   23 mEq/L
   4.0 mEq/L
   100 mg/dL
   93 mEq/L
   132 mEq/L
   23.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, Ca++:8.7 mg/dL, Mg++:2.2
   mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA)
   - will place swan to assess fluid status. For now  on milrinone at
   0.75mcg/kg/min and furosemide 20mg/hr.
   - continue bblocker 6.5 [**Hospital1 **] while on milrinone
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.
   - monitor on TELE, continue dig (level recently 1.3)
   .
   # Hypotension: Secondary to severe CHF. Patient is asymptomatic,
   mentating and making urine. Will initiate milrinone which could
   potentially worsen SVR and hypotension.
   - Consider vasopressin 0.04 mg/kg/min if drops BPs
   - monitor mental status and urine output
   - Thigh cuff for BP measurements
   - Will hold Imdur, but continue Metoprolol
   .
   # Acute on Chronic Renal Failure: Creatinine UP to 2.7.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Will touch base with Dr [**Last Name (STitle) **] (outpt hematologist) to reassess
   prognosis in setting of CHF for ? involvement of palliative care and ?
   need for inpt consult.
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   - 1500cc fluid restriction
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]
   # DISPO: CCU team for now
                        Active Medications [**Known lastname 6446**],[**Known firstname **] A.
                       22. Pravastatin 20 mg PO DAILY
   15. Heparin 5000 UNIT SC TID
   6. Aspirin 81 mg PO DAILY
   16. Insulin SC  (per Insulin Flowsheet)
   10. Clopidogrel 75 mg PO DAILY
   19. Multivitamins 1 TAB PO DAILY
   17. Metoprolol Tartrate 6.25 mg PO BID
   20. Nitroglycerin SL 0.3 mg SL PRN
   14. Furosemide 0-20 mg/hr IV DRIP
   21. Ondansetron 4 mg IV Q8H:PRN nausea
   18. Milrinone 0.5-0.75 mcg/kg/min IV DRIP INFUSION
   7. Bisacodyl 10 mg PO DAILY:PRN
   11. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)
   23. Senna 1 TAB PO BID:PRN
   12. Epoetin Alfa 3000 UNIT SC QMOWEFR
   4. Acetaminophen 325-650 mg PO Q6H:PRN
   13. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]
   5. Albuterol MDI 2 PUFF IH Q6H:PRN
   27. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain
   26. Tiotropium Bromide 1 CAP IH DAILY
   28. traZODONE 25 mg PO HS:PRN Insomnia
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
   Not putting out enough urine on Lasix drip, increased to 20mg/hr,
   increased Milrinone to 0.75mcg/kg/min and given 2 doses of diuril.
   Pacer settings changed for CHB of unknown etiology causing bradycardia.
   Now set at DDD with HR 80s.
   ROS: Pt complains of right elbow pain.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Furosemide (Lasix) - 20 mg/hour
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2203-11-4**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 35.7
C (96.3
   HR: 84 (43 - 89) bpm
   BP: 94/46(57) {89/40(52) - 119/66(77)} mmHg
   RR: 17 (10 - 31) insp/min
   SpO2: 99% on 4L
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,144 mL
                                                                    189 mL
   PO:
                                                                    750 mL
             TF:
   IVF:
                                                                    394 mL
                                                                    189 mL
   Blood products:
   Total out:
                                                                  1,365 mL
                                                                    155 mL
   Urine:
                                                                  1,165 mL
                                                                    155 mL
   NG:
                                                                    200 mL
   Stool:
   Drains:
   Balance:
                                                                   -221 mL
                                                                     34 mL
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   115 K/uL
   7.3 g/dL
   135 mg/dL
   2.7 mg/dL
   23 mEq/L
   4.0 mEq/L
   100 mg/dL
   93 mEq/L
   132 mEq/L
   23.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, Ca++:8.7 mg/dL, Mg++:2.2
   mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA)
   - will place swan to assess fluid status. For now  on milrinone at
   0.75mcg/kg/min and furosemide 20mg/hr.
   - continue bblocker 6.5 [**Hospital1 **] while on milrinone
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.
   - monitor on TELE, continue dig (level recently 1.3)
   .
   # Hypotension: Secondary to severe CHF. Patient is asymptomatic,
   mentating and making urine. Will initiate milrinone which could
   potentially worsen SVR and hypotension.
   - Consider vasopressin 0.04 mg/kg/min if drops BPs
   - monitor mental status and urine output
   - Thigh cuff for BP measurements
   - Will hold Imdur, but continue Metoprolol
   .
   # Acute on Chronic Renal Failure: Creatinine UP to 2.7.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Will touch base with Dr [**Last Name (STitle) **] (outpt hematologist) to reassess
   prognosis in setting of CHF for ? involvement of palliative care and ?
   need for inpt consult.
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   - 1500cc fluid restriction
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]
   # DISPO: CCU team for now
                        Active Medications [**Known lastname 6446**],[**Known firstname **] A.
                       22. Pravastatin 20 mg PO DAILY
   15. Heparin 5000 UNIT SC TID
   6. Aspirin 81 mg PO DAILY
   16. Insulin SC  (per Insulin Flowsheet)
   10. Clopidogrel 75 mg PO DAILY
   19. Multivitamins 1 TAB PO DAILY
   17. Metoprolol Tartrate 6.25 mg PO BID
   20. Nitroglycerin SL 0.3 mg SL PRN
   14. Furosemide 0-20 mg/hr IV DRIP
   21. Ondansetron 4 mg IV Q8H:PRN nausea
   18. Milrinone 0.5-0.75 mcg/kg/min IV DRIP INFUSION
   7. Bisacodyl 10 mg PO DAILY:PRN
   11. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)
   23. Senna 1 TAB PO BID:PRN
   12. Epoetin Alfa 3000 UNIT SC QMOWEFR
   4. Acetaminophen 325-650 mg PO Q6H:PRN
   13. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]
   5. Albuterol MDI 2 PUFF IH Q6H:PRN
   27. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain
   26. Tiotropium Bromide 1 CAP IH DAILY
   28. traZODONE 25 mg PO HS:PRN Insomnia<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following medical complications can arise:

1. Acute on Chronic Renal Failure: The patient's creatinine level is increasing, indicating worsening kidney function. This can lead to electrolyte imbalances, fluid overload, and potentially life-threatening complications.
2. Hypotension: The patient's blood pressure is low, which can be exacerbated by the use of milrinone. This can lead to decreased cardiac output, organ hypoperfusion, and potentially life-threatening complications.
3. Bradycardia: The patient's heart rate is slow, which can be a sign of a serious cardiac condition. This can lead to decreased cardiac output, organ hypoperfusion, and potentially life-threatening complications.
4. CHF: The patient has severe CHF, which can lead to fluid overload, electrolyte imbalances, and potentially life-threatening complications.
5. Anemia/Myelodysplastic Syndrome: The patient has anemia and myelodysplastic syndrome, which can lead to fatigue, weakness, and potentially life-threatening complications.
6. Elbow pain: The patient is experiencing elbow pain, which can be a sign of a serious underlying condition. This can lead to decreased mobility, decreased quality of life, and potentially life-threatening complications.
7. Diabetes Mellitus: The patient has diabetes mellitus, which can lead to hyperglycemia, ketoacidosis, and potentially life-threatening complications.
8. Fluid overload: The patient is receiving diuretic therapy, which can lead to fluid overload if not managed properly.
9. Electrolyte imbalances: The patient's electrolyte levels are abnormal, which can lead to muscle weakness, cardiac arrhythmias, and potentially life-threatening complications.

Based on the patient's medical history and current condition, the following assessments and plans are recommended:

1. Continue milrinone therapy to augment diuresis and improve cardiac function.
2. Monitor the patient's blood pressure, heart rate, and electrolyte levels closely.
3. Adjust diuretic therapy as needed to manage fluid overload and electrolyte imbalances.
4. Consider vasopressin therapy if the patient's blood pressure drops.
5. Monitor the patient's renal function closely to assess for worsening kidney function.
6. Continue cardiac medications, including aspirin, clopidogrel, and metoprolol, to manage CHF and cardiac arrhythmias.
7. Monitor the patient's glucose levels closely to manage diabetes mellitus.
8. Consider referring the patient to a palliative care specialist to assess for potential involvement in end-of-life care.
9. Consider referring the patient to a nephrologist to assess for potential involvement in kidney disease management."
171419.0,259757,2203-11-04 06:45:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
   Not putting out enough urine on Lasix drip, increased to 20mg/hr,
   increased Milrinone to 0.75mcg/kg/min and given 2 doses of diuril.
   Pacer settings changed for CHB of unknown etiology causing bradycardia.
   Now set at DDD with HR 80s.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Furosemide (Lasix) - 20 mg/hour
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2203-11-4**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 35.7
C (96.3
   HR: 84 (43 - 89) bpm
   BP: 94/46(57) {89/40(52) - 119/66(77)} mmHg
   RR: 17 (10 - 31) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,144 mL
                                                                    189 mL
   PO:
                                                                    750 mL
             TF:
   IVF:
                                                                    394 mL
                                                                    189 mL
   Blood products:
   Total out:
                                                                  1,365 mL
                                                                    155 mL
   Urine:
                                                                  1,165 mL
                                                                    155 mL
   NG:
                                                                    200 mL
   Stool:
   Drains:
   Balance:
                                                                   -221 mL
                                                                     34 mL
   Physical Examination
   GENERAL: WDWN, African-American female, sleepy but cooperative. A+O x 3
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Oral mucosa moist.
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding. Abd aorta not enlarged by palpation.
   No abdominial bruits.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.
   SKIN: Multiple areas of hyperpigmentation
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   115 K/uL
   7.3 g/dL
   135 mg/dL
   2.7 mg/dL
   23 mEq/L
   4.0 mEq/L
   100 mg/dL
   93 mEq/L
   132 mEq/L
   23.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, Ca++:8.7 mg/dL, Mg++:2.2
   mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone
   [**11-2**] [**Doctor Last Name **] recs
   - start milrinone: give 50mcg/kg bolus over 15 minutes, then start
   0.375mcg/kg/min titrate to goal 0.5mcg/kg/min. Will titrate to urine
   output, decrease edema, Cr decrease
   - Start milrinone 30min prior to administering lasix
   - Give lasix 60mg IV x 1 and start drip at 7micrograms/hr.
   - Goal 1L negative
   - continue bblocker 12.5 [**Hospital1 **] while on milrinone
   - Monitor lytes with diuresis
   - Daily I&Os
   - Daily Weights
   - Continue Digoxin
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.
   - monitor on TELE
   .
   # Hypotension: Secondary to severe CHF. Patient is asymptomatic,
   mentating and making urine. Will initiate milrinone which could
   potentially worsen SVR and hypotension.
   - Consider vasopressin 0.04 mg/kg/min if drops BPs
   - monitor mental status and urine output
   - Thigh cuff for BP measurements
   - Will hold Imdur, but continue Metoprolol
   .
   # Acute on Chronic Renal Failure: Creatinine UP to 2.7.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva
   - Continue Albuterol
   - Continue Fluticasone
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Continue to monitor
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   - 1500cc fluid restriction
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]
   # DISPO: CCU team for now
                        Active Medications [**Known lastname 6446**],[**Known firstname **] A.
                       22. Pravastatin 20 mg PO DAILY
   15. Heparin 5000 UNIT SC TID
   6. Aspirin 81 mg PO DAILY
   16. Insulin SC  (per Insulin Flowsheet)
   10. Clopidogrel 75 mg PO DAILY
   19. Multivitamins 1 TAB PO DAILY
   17. Metoprolol Tartrate 6.25 mg PO BID
   20. Nitroglycerin SL 0.3 mg SL PRN
   14. Furosemide 0-20 mg/hr IV DRIP
   21. Ondansetron 4 mg IV Q8H:PRN nausea
   18. Milrinone 0.5-0.75 mcg/kg/min IV DRIP INFUSION
   7. Bisacodyl 10 mg PO DAILY:PRN
   11. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)
   23. Senna 1 TAB PO BID:PRN
   12. Epoetin Alfa 3000 UNIT SC QMOWEFR
   4. Acetaminophen 325-650 mg PO Q6H:PRN
   13. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]
   5. Albuterol MDI 2 PUFF IH Q6H:PRN
   27. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain
   26. Tiotropium Bromide 1 CAP IH DAILY
   28. traZODONE 25 mg PO HS:PRN Insomnia
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
   Not putting out enough urine on Lasix drip, increased to 20mg/hr,
   increased Milrinone to 0.75mcg/kg/min and given 2 doses of diuril.
   Pacer settings changed for CHB of unknown etiology causing bradycardia.
   Now set at DDD with HR 80s.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Furosemide (Lasix) - 20 mg/hour
   Other ICU medications:
   Other medications:
   Flowsheet Data as of  [**2203-11-4**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (99
   Tcurrent: 35.7
C (96.3
   HR: 84 (43 - 89) bpm
   BP: 94/46(57) {89/40(52) - 119/66(77)} mmHg
   RR: 17 (10 - 31) insp/min
   SpO2: 99%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,144 mL
                                                                    189 mL
   PO:
                                                                    750 mL
             TF:
   IVF:
                                                                    394 mL
                                                                    189 mL
   Blood products:
   Total out:
                                                                  1,365 mL
                                                                    155 mL
   Urine:
                                                                  1,165 mL
                                                                    155 mL
   NG:
                                                                    200 mL
   Stool:
   Drains:
   Balance:
                                                                   -221 mL
                                                                     34 mL
   Physical Examination
   GENERAL: WDWN, African-American female, sleepy but cooperative. A+O x 3
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Oral mucosa moist.
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding. Abd aorta not enlarged by palpation.
   No abdominial bruits.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.
   SKIN: Multiple areas of hyperpigmentation
   PULSES:
   Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ PT 2+
   Labs / Radiology
   115 K/uL
   7.3 g/dL
   135 mg/dL
   2.7 mg/dL
   23 mEq/L
   4.0 mEq/L
   100 mg/dL
   93 mEq/L
   132 mEq/L
   23.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, Ca++:8.7 mg/dL, Mg++:2.2
   mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone
   [**11-2**] [**Doctor Last Name **] recs
   - start milrinone: give 50mcg/kg bolus over 15 minutes, then start
   0.375mcg/kg/min titrate to goal 0.5mcg/kg/min. Will titrate to urine
   output, decrease edema, Cr decrease
   - Start milrinone 30min prior to administering lasix
   - Give lasix 60mg IV x 1 and start drip at 7micrograms/hr.
   - Goal 1L negative
   - continue bblocker 12.5 [**Hospital1 **] while on milrinone
   - Monitor lytes with diuresis
   - Daily I&Os
   - Daily Weights
   - Continue Digoxin
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.
   - monitor on TELE
   .
   # Hypotension: Secondary to severe CHF. Patient is asymptomatic,
   mentating and making urine. Will initiate milrinone which could
   potentially worsen SVR and hypotension.
   - Consider vasopressin 0.04 mg/kg/min if drops BPs
   - monitor mental status and urine output
   - Thigh cuff for BP measurements
   - Will hold Imdur, but continue Metoprolol
   .
   # Acute on Chronic Renal Failure: Creatinine UP to 2.7.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva
   - Continue Albuterol
   - Continue Fluticasone
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Continue to monitor
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   - 1500cc fluid restriction
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]
   # DISPO: CCU team for now
                        Active Medications [**Known lastname 6446**],[**Known firstname **] A.
                       22. Pravastatin 20 mg PO DAILY
   15. Heparin 5000 UNIT SC TID
   6. Aspirin 81 mg PO DAILY
   16. Insulin SC  (per Insulin Flowsheet)
   10. Clopidogrel 75 mg PO DAILY
   19. Multivitamins 1 TAB PO DAILY
   17. Metoprolol Tartrate 6.25 mg PO BID
   20. Nitroglycerin SL 0.3 mg SL PRN
   14. Furosemide 0-20 mg/hr IV DRIP
   21. Ondansetron 4 mg IV Q8H:PRN nausea
   18. Milrinone 0.5-0.75 mcg/kg/min IV DRIP INFUSION
   7. Bisacodyl 10 mg PO DAILY:PRN
   11. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)
   23. Senna 1 TAB PO BID:PRN
   12. Epoetin Alfa 3000 UNIT SC QMOWEFR
   4. Acetaminophen 325-650 mg PO Q6H:PRN
   13. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]
   5. Albuterol MDI 2 PUFF IH Q6H:PRN
   27. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain
   26. Tiotropium Bromide 1 CAP IH DAILY
   28. traZODONE 25 mg PO HS:PRN Insomnia<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 68-year-old female with a complex medical history, including coronary artery disease (CAD) status post 4-vessel coronary artery bypass grafting (CABG) and subsequent stent placement in the left anterior descending (LAD) artery. She has also undergone restenting due to instent stenosis.

The patient is currently in the intensive care unit (ICU) with acute on chronic renal failure, with a creatinine level of 2.7 mg/dL. She is receiving milrinone, a phosphodiesterase inhibitor, to increase renal perfusion and diuresis. The patient's cardiac status is also being monitored, as she has a history of severe heart failure with an ejection fraction of 20-30%. She is being treated with dobutamine and milrinone, and her pacer settings have been changed to DDD with a heart rate of 80s.

The patient's laboratory results show abnormal values, including:

* Creatinine: 2.7 mg/dL
* Blood urea nitrogen (BUN): 23 mg/dL
* Sodium: 135 mg/dL
* Potassium: 4.0 mEq/L
* Calcium: 8.7 mg/dL
* Magnesium: 2.2 mg/dL
* Phosphorus: 4.3 mg/dL
* Hemoglobin: 7.3 g/dL
* Hematocrit: 27.0%
* White blood cell count: 1.6 K/uL
* Platelet count: 121 K/uL

Based on these laboratory results, the patient is at risk for the following potential medical complications:

* Acute kidney injury (AKI) due to acute on chronic renal failure
* Electrolyte imbalance due to decreased renal function and diuretic therapy
* Cardiac arrhythmias due to changes in electrolyte levels and cardiac medications
* Respiratory failure due to decreased lung function and increased risk of pneumonia
* Infection due to decreased immune function and increased risk of sepsis
* Bleeding due to decreased platelet count and increased risk of hemorrhage
* Anemia due to decreased red blood cell production and increased risk of transfusion

To manage these potential complications, the patient should be closely monitored for signs of AKI, electrolyte imbalance, cardiac arrhythmias, respiratory failure, infection, bleeding, and anemia. The patient's medication regimen should be adjusted as necessary to prevent and treat these complications."
171419.0,259757,2203-11-05 06:17:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Heme-Onc (Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1391**] & [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]) evaulated.  MDS not likely to
   interact with CHF.  To them, CHF seems to be process limiting
   life-expectancy.
   Transfused 1 U.
   Repeat labs with elevated Cr.  Small IVF bolus given.
   Palliative care came by.  Will meet with patient officially on Monday.
   VT on tele ~ 20 s runs.  Assymptomatic
   S:  Feels better.  Still c/o elbow pain but that is slightly improved.
   No CP, SOB
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2203-11-5**] 05:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98.1
   Tcurrent: 36.7
C (98.1
   HR: 88 (71 - 91) bpm
   BP: 99/46(59) {93/46(57) - 119/71(94)} mmHg
   RR: 22 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,580 mL
                                                                    386 mL
   PO:
                                                                    770 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    529 mL
                                                                    336 mL
   Blood products:
                                                                    281 mL
   Total out:
                                                                    895 mL
                                                                    330 mL
   Urine:
                                                                    895 mL
                                                                    330 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    685 mL
                                                                     56 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ////
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
                                     131
                               [image002.gif]
                                     94
                               [image002.gif]
                                     99
   [image004.gif]
   124
                                                                   AGap=17
   [image005.gif]
   3.8
                               [image002.gif]
                                     24
                               [image002.gif]
                                     2.7
   [image007.gif]
   Mg: 2.2
   Source: Line-picc
   0
                                                                       2.0
                                                            [image007.gif]
                                     0 D
   [image004.gif]
   118
                 [image008.gif]
   [image004.gif]
                                     27
   [image007.gif]
   Source: [**Name (NI) 2419**]
   PT: 15.3
   PTT: 28.3
   INR: 1.3
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   3.0
   TropT
   0.54
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.7 mg/dL, Mg++:2.2 mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA).  Patient felt
   to by dry.  Gentle rehydration started and lasix stopped.
   - wean milrinone
   - continue bblocker 6.5
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.   V Tach yesterday.  Has
   ICD.
   - monitor on TELE, continue dig (level recently 1.3)
   - lytes, beta-blocker
   .
   # Acute on Chronic Renal Failure: Improved following gentle rehydration
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - xfuse as needed
   - appreciarte onc input
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: CCU while on milrinone
           1. IV access: Peripheral line Order date: [**11-3**] @ 0341
   14. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-3**] @ 0341
   2. IV access: PICC, heparin dependent Location: Right, Date inserted:
   [**2203-11-2**] Order date: [**11-3**] @ 0341
   15. Metoprolol Tartrate 6.25 mg PO BID
   Hold for SBP < 100, HR < 60   Order date: [**11-3**] @ 1126
   3. IV access: Peripheral line Order date: [**11-3**] @ 0341
   16. Multivitamins 1 TAB PO DAILY  Order date: [**11-3**] @ 0341
   4. 250 mL NS Bolus 250 ml Over 60 mins Order date: [**11-4**] @ 2356
   17. Nitroglycerin SL 0.3 mg SL PRN chest pain  Order date: [**11-3**] @ 0341
   5. Acetaminophen 325-650 mg PO Q6H:PRN Pain/Fever  Order date: [**11-3**] @
   0341
   18. Ondansetron 4 mg IV Q8H:PRN nausea  Order date: [**11-3**] @ 0924
   6. Albuterol MDI 2 PUFF IH Q6H:PRN Shortness of Breath/Wheezing  Order
   date: [**11-3**] @ 0341
   19. Potassium Chloride 20 mEq PO ONCE Duration: 1 Doses Order date:
   [**11-5**] @ 0005
   7. Aspirin 81 mg PO DAILY Start: In am Order date: [**11-3**] @ 0341
   20. Pravastatin 20 mg PO DAILY  Order date: [**11-3**] @ 0341
   8. Bisacodyl 10 mg PO DAILY:PRN  Order date: [**11-3**] @ 0341
   21. Senna 1 TAB PO BID:PRN  Order date: [**11-3**] @ 0341
   9. Clopidogrel 75 mg PO DAILY  Order date: [**11-3**] @ 0341
   22. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   10. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)  Order date: [**11-3**] @ 0341
   23. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   11. Epoetin Alfa 3000 UNIT SC QMOWEFR Start: HS Order date: [**11-3**] @
   0341
   24. Tiotropium Bromide 1 CAP IH DAILY  Order date: [**11-3**] @ 0341
   12. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]  Order date: [**11-3**] @
   0341
   25. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain  Order date: [**11-3**] @
   0341
   13. Heparin 5000 UNIT SC TID  Order date: [**11-3**] @ 0341
   26. traZODONE 25 mg PO HS:PRN Insomnia  Order date: [**11-3**] @ 0341
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Heme-Onc (Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1391**] & [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]) evaulated.  MDS not likely to
   interact with CHF.  To them, CHF seems to be process limiting
   life-expectancy.
   Transfused 1 U.
   Repeat labs with elevated Cr.  Small IVF bolus given.
   Palliative care came by.  Will meet with patient officially on Monday.
   VT on tele ~ 20 s runs.  Assymptomatic
   S:  Feels better.  Still c/o elbow pain but that is slightly improved.
   No CP, SOB
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2203-11-5**] 05:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98.1
   Tcurrent: 36.7
C (98.1
   HR: 88 (71 - 91) bpm
   BP: 99/46(59) {93/46(57) - 119/71(94)} mmHg
   RR: 22 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,580 mL
                                                                    386 mL
   PO:
                                                                    770 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    529 mL
                                                                    336 mL
   Blood products:
                                                                    281 mL
   Total out:
                                                                    895 mL
                                                                    330 mL
   Urine:
                                                                    895 mL
                                                                    330 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    685 mL
                                                                     56 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ////
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
                                     131
                               [image002.gif]
                                     94
                               [image002.gif]
                                     99
   [image004.gif]
   124
                                                                   AGap=17
   [image005.gif]
   3.8
                               [image002.gif]
                                     24
                               [image002.gif]
                                     2.7
   [image007.gif]
   Mg: 2.2
   Source: Line-picc
   0
                                                                       2.0
                                                            [image007.gif]
                                     0 D
   [image004.gif]
   118
                 [image008.gif]
   [image004.gif]
                                     27
   [image007.gif]
   Source: [**Name (NI) 2419**]
   PT: 15.3
   PTT: 28.3
   INR: 1.3
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   3.0
   TropT
   0.54
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.7 mg/dL, Mg++:2.2 mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA).  Patient felt
   to by dry.  Gentle rehydration started and lasix stopped.
   - wean milrinone
   - continue bblocker 6.5
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.   V Tach yesterday.  Has
   ICD.
   - monitor on TELE, continue dig (level recently 1.3)
   - lytes, beta-blocker
   .
   # Acute on Chronic Renal Failure: Improved following gentle rehydration
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - xfuse as needed
   - appreciarte onc input
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: CCU while on milrinone
           1. IV access: Peripheral line Order date: [**11-3**] @ 0341
   14. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-3**] @ 0341
   2. IV access: PICC, heparin dependent Location: Right, Date inserted:
   [**2203-11-2**] Order date: [**11-3**] @ 0341
   15. Metoprolol Tartrate 6.25 mg PO BID
   Hold for SBP < 100, HR < 60   Order date: [**11-3**] @ 1126
   3. IV access: Peripheral line Order date: [**11-3**] @ 0341
   16. Multivitamins 1 TAB PO DAILY  Order date: [**11-3**] @ 0341
   4. 250 mL NS Bolus 250 ml Over 60 mins Order date: [**11-4**] @ 2356
   17. Nitroglycerin SL 0.3 mg SL PRN chest pain  Order date: [**11-3**] @ 0341
   5. Acetaminophen 325-650 mg PO Q6H:PRN Pain/Fever  Order date: [**11-3**] @
   0341
   18. Ondansetron 4 mg IV Q8H:PRN nausea  Order date: [**11-3**] @ 0924
   6. Albuterol MDI 2 PUFF IH Q6H:PRN Shortness of Breath/Wheezing  Order
   date: [**11-3**] @ 0341
   19. Potassium Chloride 20 mEq PO ONCE Duration: 1 Doses Order date:
   [**11-5**] @ 0005
   7. Aspirin 81 mg PO DAILY Start: In am Order date: [**11-3**] @ 0341
   20. Pravastatin 20 mg PO DAILY  Order date: [**11-3**] @ 0341
   8. Bisacodyl 10 mg PO DAILY:PRN  Order date: [**11-3**] @ 0341
   21. Senna 1 TAB PO BID:PRN  Order date: [**11-3**] @ 0341
   9. Clopidogrel 75 mg PO DAILY  Order date: [**11-3**] @ 0341
   22. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   10. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)  Order date: [**11-3**] @ 0341
   23. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   11. Epoetin Alfa 3000 UNIT SC QMOWEFR Start: HS Order date: [**11-3**] @
   0341
   24. Tiotropium Bromide 1 CAP IH DAILY  Order date: [**11-3**] @ 0341
   12. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]  Order date: [**11-3**] @
   0341
   25. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain  Order date: [**11-3**] @
   0341
   13. Heparin 5000 UNIT SC TID  Order date: [**11-3**] @ 0341
   26. traZODONE 25 mg PO HS:PRN Insomnia  Order date: [**11-3**] @ 0341<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 68-year-old female with a complex medical history, including:

1. Coronary Artery Disease (CAD) with a history of 4-vessel CABG and stenting of the LIMA-LAD artery.
2. Severe Chronic Heart Failure (CHF) with an ejection fraction of 20-30%.
3. Acute on Chronic Renal Failure (ACRF) with elevated creatinine levels.
4. Myelodysplastic Syndrome (MDS) at baseline.
5. History of ICD implantation.
6. Recent discharge with acute on chronic renal failure.

The patient was admitted to the ICU for further management of her condition. The note highlights the following key points:

1. The patient's condition has improved following gentle rehydration and diuresis.
2. The patient's creatinine levels have decreased, but remain elevated.
3. The patient's blood pressure is stable, but her heart rate is slightly elevated.
4. The patient's oxygen saturation is 96% on room air.
5. The patient's cardiac rhythm is ventricular-paced.
6. The patient's physical examination reveals bilateral elbow swelling and point tenderness at the point of tendon insertion to the humerus.

Potential medical complications that can arise from the patient's condition include:

1. Worsening of CHF and ACRF, leading to further decreases in renal function.
2. Development of arrhythmias, including ventricular tachycardia or fibrillation, due to the patient's history of ICD implantation.
3. Infection, particularly given the patient's history of MDS and recent discharge.
4. Gastrointestinal bleeding or perforation due to the patient's history of CHF and ACRF.
5. Respiratory failure due to the patient's history of CHF and ACRF.

The patient's treatment plan includes:

1. Continued management of CHF with milrinone and diuresis.
2. Monitoring of renal function and electrolyte levels.
3. Management of MDS with transfusions as needed.
4. Monitoring of the patient's cardiac rhythm and adjusting the pacemaker settings as necessary.
5. Providing supportive care, including pain management and respiratory support as needed.

Overall, the patient requires close monitoring and management to prevent potential complications and optimize her clinical outcomes."
171419.0,259757,2203-11-05 06:17:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Heme-Onc (Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1391**] & [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]) evaulated.  MDS not likely to
   interact with CHF.  To them, CHF seems to be process limiting
   life-expectancy.
   VT on tele.
   Transfused 1 U.
   Repeat labs with elevated Cr.  Small IVF bolus given.
   Palliative care came by.  Will meet with patient officially on Monday.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2203-11-5**] 05:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98.1
   Tcurrent: 36.7
C (98.1
   HR: 88 (71 - 91) bpm
   BP: 99/46(59) {93/46(57) - 119/71(94)} mmHg
   RR: 22 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,580 mL
                                                                    386 mL
   PO:
                                                                    770 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    529 mL
                                                                    336 mL
   Blood products:
                                                                    281 mL
   Total out:
                                                                    895 mL
                                                                    330 mL
   Urine:
                                                                    895 mL
                                                                    330 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    685 mL
                                                                     56 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ////
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   3.0
   TropT
   0.54
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.7 mg/dL, Mg++:2.2 mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA).  Patient felt
   to by dry.  Gentle rehydration started and lasix stopped.
   - wean milrinone
   - continue bblocker 6.5
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.   V Tach yesterday
   - monitor on TELE, continue dig (level recently 1.3)
   - lytes, beta-blocker
   .
   # Acute on Chronic Renal Failure: Creatinine continues to rise.  Will
   rehydrate to lower.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - xfuse as needed
   - appreciarte onc input
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: CCU team for now
           1. IV access: Peripheral line Order date: [**11-3**] @ 0341
   14. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-3**] @ 0341
   2. IV access: PICC, heparin dependent Location: Right, Date inserted:
   [**2203-11-2**] Order date: [**11-3**] @ 0341
   15. Metoprolol Tartrate 6.25 mg PO BID
   Hold for SBP < 100, HR < 60   Order date: [**11-3**] @ 1126
   3. IV access: Peripheral line Order date: [**11-3**] @ 0341
   16. Multivitamins 1 TAB PO DAILY  Order date: [**11-3**] @ 0341
   4. 250 mL NS Bolus 250 ml Over 60 mins Order date: [**11-4**] @ 2356
   17. Nitroglycerin SL 0.3 mg SL PRN chest pain  Order date: [**11-3**] @ 0341
   5. Acetaminophen 325-650 mg PO Q6H:PRN Pain/Fever  Order date: [**11-3**] @
   0341
   18. Ondansetron 4 mg IV Q8H:PRN nausea  Order date: [**11-3**] @ 0924
   6. Albuterol MDI 2 PUFF IH Q6H:PRN Shortness of Breath/Wheezing  Order
   date: [**11-3**] @ 0341
   19. Potassium Chloride 20 mEq PO ONCE Duration: 1 Doses Order date:
   [**11-5**] @ 0005
   7. Aspirin 81 mg PO DAILY Start: In am Order date: [**11-3**] @ 0341
   20. Pravastatin 20 mg PO DAILY  Order date: [**11-3**] @ 0341
   8. Bisacodyl 10 mg PO DAILY:PRN  Order date: [**11-3**] @ 0341
   21. Senna 1 TAB PO BID:PRN  Order date: [**11-3**] @ 0341
   9. Clopidogrel 75 mg PO DAILY  Order date: [**11-3**] @ 0341
   22. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   10. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)  Order date: [**11-3**] @ 0341
   23. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   11. Epoetin Alfa 3000 UNIT SC QMOWEFR Start: HS Order date: [**11-3**] @
   0341
   24. Tiotropium Bromide 1 CAP IH DAILY  Order date: [**11-3**] @ 0341
   12. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]  Order date: [**11-3**] @
   0341
   25. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain  Order date: [**11-3**] @
   0341
   13. Heparin 5000 UNIT SC TID  Order date: [**11-3**] @ 0341
   26. traZODONE 25 mg PO HS:PRN Insomnia  Order date: [**11-3**] @ 0341
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Heme-Onc (Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1391**] & [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **]) evaulated.  MDS not likely to
   interact with CHF.  To them, CHF seems to be process limiting
   life-expectancy.
   VT on tele.
   Transfused 1 U.
   Repeat labs with elevated Cr.  Small IVF bolus given.
   Palliative care came by.  Will meet with patient officially on Monday.
   Allergies:
   Lipitor (Oral) (Atorvastatin Calcium)
   Rash;
   Lisinopril
   Rash;
   Iodine
   Unknown;
   Paper Tape (Topical) (Adhesive Tape)
   Rash;
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.75 mcg/Kg/min
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2203-11-5**] 05:56 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.7
C (98.1
   Tcurrent: 36.7
C (98.1
   HR: 88 (71 - 91) bpm
   BP: 99/46(59) {93/46(57) - 119/71(94)} mmHg
   RR: 22 (13 - 25) insp/min
   SpO2: 96%
   Heart rhythm: V Paced
   Height: 61 Inch
             Total In:
                                                                  1,580 mL
                                                                    386 mL
   PO:
                                                                    770 mL
                                                                     50 mL
   TF:
   IVF:
                                                                    529 mL
                                                                    336 mL
   Blood products:
                                                                    281 mL
   Total out:
                                                                    895 mL
                                                                    330 mL
   Urine:
                                                                    895 mL
                                                                    330 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    685 mL
                                                                     56 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ////
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins. Strength and sensation in tact
   symmetrically.  Bilateral elbow swelling, point tenderness at point of
   tendon insertion to humerus.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
   WBC
   1.6
   2.0
   Hct
   27.0
   23.5
   Plt
   121
   115
   Cr
   2.2
   2.4
   2.7
   3.0
   TropT
   0.54
   Glucose
   106
   235
   135
   Other labs: PT / PTT / INR:15.5/29.0/1.4, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.7 mg/dL, Mg++:2.2 mg/dL, PO4:4.3 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD and recent admit to CCU requiring
   dobutamine. Followed by [**Doctor Last Name **] and transferred from floor for initiation
   of milrinone to augment diuresis. Other than peripheral edema and neck
   veins pt appears dry (climbing Cr, satting well on RA).  Patient felt
   to by dry.  Gentle rehydration started and lasix stopped.
   - wean milrinone
   - continue bblocker 6.5
   - Monitor lytes with diuresis
   - Daily I&Os, weights
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes.   V Tach yesterday
   - monitor on TELE, continue dig (level recently 1.3)
   - lytes, beta-blocker
   .
   # Acute on Chronic Renal Failure: Creatinine continues to rise.  Will
   rehydrate to lower.
   - Increased milrinone to increase renal perfusion
   - check urine lytes for feUrea
   .
   # Asthma
   - Continue Spiriva, albuterol, fluticasone
   - Satting well.
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - xfuse as needed
   - appreciarte onc input
   .
   # Elbow pain
   - Location not consistent with gout/psuedogout or bursitis. Unclear
   etiology. Tylenol prn.
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN
   - Correct/Replete electrolytes PRN
   - Diabetic/Cardiac diet
   # ACCESS: Right EJ
   # PROPHYLAXIS:
   - SC Heparin
   - Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: CCU team for now
           1. IV access: Peripheral line Order date: [**11-3**] @ 0341
   14. Insulin SC  (per Insulin Flowsheet)
         Sliding Scale Order date: [**11-3**] @ 0341
   2. IV access: PICC, heparin dependent Location: Right, Date inserted:
   [**2203-11-2**] Order date: [**11-3**] @ 0341
   15. Metoprolol Tartrate 6.25 mg PO BID
   Hold for SBP < 100, HR < 60   Order date: [**11-3**] @ 1126
   3. IV access: Peripheral line Order date: [**11-3**] @ 0341
   16. Multivitamins 1 TAB PO DAILY  Order date: [**11-3**] @ 0341
   4. 250 mL NS Bolus 250 ml Over 60 mins Order date: [**11-4**] @ 2356
   17. Nitroglycerin SL 0.3 mg SL PRN chest pain  Order date: [**11-3**] @ 0341
   5. Acetaminophen 325-650 mg PO Q6H:PRN Pain/Fever  Order date: [**11-3**] @
   0341
   18. Ondansetron 4 mg IV Q8H:PRN nausea  Order date: [**11-3**] @ 0924
   6. Albuterol MDI 2 PUFF IH Q6H:PRN Shortness of Breath/Wheezing  Order
   date: [**11-3**] @ 0341
   19. Potassium Chloride 20 mEq PO ONCE Duration: 1 Doses Order date:
   [**11-5**] @ 0005
   7. Aspirin 81 mg PO DAILY Start: In am Order date: [**11-3**] @ 0341
   20. Pravastatin 20 mg PO DAILY  Order date: [**11-3**] @ 0341
   8. Bisacodyl 10 mg PO DAILY:PRN  Order date: [**11-3**] @ 0341
   21. Senna 1 TAB PO BID:PRN  Order date: [**11-3**] @ 0341
   9. Clopidogrel 75 mg PO DAILY  Order date: [**11-3**] @ 0341
   22. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   10. Digoxin 0.125 mg PO 3X/WEEK (MO,WE,FR)  Order date: [**11-3**] @ 0341
   23. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**11-3**] @ 0341
   11. Epoetin Alfa 3000 UNIT SC QMOWEFR Start: HS Order date: [**11-3**] @
   0341
   24. Tiotropium Bromide 1 CAP IH DAILY  Order date: [**11-3**] @ 0341
   12. Fluticasone Propionate 110mcg 2 PUFF IH [**Hospital1 **]  Order date: [**11-3**] @
   0341
   25. TraMADOL (Ultram) 50 mg PO BID:PRN foot pain  Order date: [**11-3**] @
   0341
   13. Heparin 5000 UNIT SC TID  Order date: [**11-3**] @ 0341
   26. traZODONE 25 mg PO HS:PRN Insomnia  Order date: [**11-3**] @ 0341<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 68-year-old African-American female with a history of coronary artery disease (CAD) status post 4-vessel coronary artery bypass grafting (CABG) and follow-up stenting of the left internal mammary artery (LIMA) to the left anterior descending (LAD) artery. She presents with acute on chronic renal failure, severe congestive heart failure (CHF) with an estimated ejection fraction (EF) of 20-30%, and a recent admission to the cardiac care unit (CCU) requiring dobutamine and milrinone to augment diuresis. The patient has a history of anemia/myelodysplastic syndrome, asthma, diabetes mellitus (DM), and has undergone stenting of the LIMA-LAD.

Progress:

The patient's condition remains stable, with continued elevation of creatinine levels. The patient has been rehydrated and lasix has been stopped. Milrinone has been increased to increase renal perfusion, and urine electrolytes are being checked for feUrea. The patient's blood pressure remains stable, with a reading of 99/46 mmHg. The patient's heart rhythm remains paced, with a heart rate of 88 beats per minute.

Potential Medical Complications:

1. Acute Kidney Injury (AKI): The patient's creatinine levels continue to rise, indicating potential kidney damage. Further monitoring and treatment are necessary to prevent AKI.
2. CHF exacerbation: The patient's CHF symptoms may worsen due to the continued elevation of creatinine levels, which can lead to further fluid accumulation and decreased cardiac output.
3. Anemia/myelodysplastic syndrome: The patient's anemia/myelodysplastic syndrome may worsen, leading to decreased oxygen delivery to tissues and potentially exacerbating existing cardiac conditions.
4. Asthma: The patient's asthma symptoms may worsen due to the continued use of bronchodilators and potential exacerbation of underlying asthma.
5. DM: The patient's DM may worsen due to the continued use of insulin and potential exacerbation of underlying diabetic complications.
6. Elbow pain: The patient's elbow pain may worsen due to the continued use of Tylenol and potential exacerbation of underlying conditions.
7. Hyperkalemia: The patient's potassium levels may continue to rise due to the use of potassium-sparing diuretics and potentially exacerbate existing cardiac conditions.

Recommendations:

1. Continue to monitor the patient's creatinine levels and adjust treatment accordingly.
2. Continue to monitor the patient's CHF symptoms and adjust treatment accordingly.
3. Consider consulting with a nephrologist to further manage the patient's AKI.
4. Continue to monitor the patient's anemia/myelodysplastic syndrome and adjust treatment accordingly.
5. Continue to monitor the patient's asthma symptoms and adjust treatment accordingly.
6. Continue to monitor the patient's DM and adjust treatment accordingly.
7. Consider consulting with an orthopedic specialist to further evaluate and manage the patient's elbow pain.
8. Monitor the patient's potassium levels and adjust treatment accordingly to prevent hyperkalemia."
171419.0,259757,2203-11-06 09:32:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
    Stopped milrinone drip, switched to PO lasix at home dose
   Allergies:
   Lipitor (Oral) Rash;
   Lisinopril Rash;
   Iodine Unknown;
   Paper Tape Rash;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2203-11-5**] 10:39 PM
   Other medications:
   Flowsheet Data as of  [**2203-11-6**] 09:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 35.4
C (95.7
   HR: 79 (65 - 95) bpm
   BP: 100/51(61) {93/51(61) - 121/80(84)} mmHg
   RR: 35 (16 - 35) insp/min
   SpO2: 98%
   Heart rhythm: V Paced
   Height: 61 Inch
                  Total In:
                                                                    711 mL
                  PO:
                                                                    290 mL
                  TF:
   IVF:
                                                                    421 mL
   Blood products:
   Total out:
                                                                  1,055 mL
                                                                    290 mL
   Urine:
                                                                  1,055 mL
                                                                    290 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -344 mL
                                                                   -290 mL
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   110 K/uL
   8.1 g/dL
   102 mg/dL
   2.3 mg/dL
   22 mEq/L
   4.4 mEq/L
   97 mg/dL
   95 mEq/L
   132 mEq/L
   24.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
                            [**2203-11-5**]  05:51 AM
                            [**2203-11-5**]  07:41 PM
                            [**2203-11-6**]  06:28 AM
   WBC
   1.6
   2.0
   2.0
   2.0
   Hct
   27.0
   23.5
   27.0
   24.5
   Plt
   121
   115
   118
   110
   Cr
   2.2
   2.4
   2.7
   3.0
   2.7
   2.6
   2.3
   TropT
   0.54
   Glucose
   106
   235
   135
   124
   102
   Other labs: PT / PTT / INR:15.3/28.3/1.3, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.6 mg/dL, Mg++:2.2 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD. Currently thought to be total body
   fluid overloaded but pt tolerating well (lungs clear, satting well,
   comfortable), so switched to PO lasix to keep even to neg.
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes
   .
   # Acute on Chronic Renal Failure: Improving
   .
   # Asthma  - Continue Spiriva, albuterol, fluticasone
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Transfuse as needed
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN   - Correct/Replete electrolytes PRN, no IVF, Diabetic/Cardiac
   diet
   # ACCESS: Right EJ
   # PROPHYLAXIS: SC Heparin, Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: to floor today
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint: 68 y.o. female with CAD s/p 4 vessel CABG and
   follow-up stent of LIMA-LAD c/b instent stenosis with restenting as
   well as severe CHF, EF of 20-30% who presents after recent discharge
   with acute on chronic renal failure.
   24 Hour Events:
    Stopped milrinone drip, switched to PO lasix at home dose
   Allergies:
   Lipitor (Oral) Rash;
   Lisinopril Rash;
   Iodine Unknown;
   Paper Tape Rash;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2203-11-5**] 10:39 PM
   Other medications:
   Flowsheet Data as of  [**2203-11-6**] 09:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.9
C (98.5
   Tcurrent: 35.4
C (95.7
   HR: 79 (65 - 95) bpm
   BP: 100/51(61) {93/51(61) - 121/80(84)} mmHg
   RR: 35 (16 - 35) insp/min
   SpO2: 98%
   Heart rhythm: V Paced
   Height: 61 Inch
                  Total In:
                                                                    711 mL
                  PO:
                                                                    290 mL
                  TF:
   IVF:
                                                                    421 mL
   Blood products:
   Total out:
                                                                  1,055 mL
                                                                    290 mL
   Urine:
                                                                  1,055 mL
                                                                    290 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -344 mL
                                                                   -290 mL
   Physical Examination
   GENERAL: WDWN, African-American female. A+O x 3
   HEENT: MMM
   NECK: Supple, torturous, bulging external vasculature.
   CARDIAC: RR, normal S1, fixed split S2. No m/r/g. No thrills, lifts. No
   S3 or S4.
   LUNGS: CTA B
   ABDOMEN: Firm in upper quadrants, NTND. No HSM, liver edge not
   palpable. No rebound or guarding.
   EXTREMITIES: No c/c; edema to mid shins.
   SKIN: Multiple areas of hyperpigmentation
   Labs / Radiology
   110 K/uL
   8.1 g/dL
   102 mg/dL
   2.3 mg/dL
   22 mEq/L
   4.4 mEq/L
   97 mg/dL
   95 mEq/L
   132 mEq/L
   24.5 %
   2.0 K/uL
        [image002.jpg]
                            [**2203-11-3**]  04:28 AM
                            [**2203-11-3**]  04:21 PM
                            [**2203-11-4**]  04:45 AM
                            [**2203-11-4**]  10:39 PM
                            [**2203-11-5**]  05:51 AM
                            [**2203-11-5**]  07:41 PM
                            [**2203-11-6**]  06:28 AM
   WBC
   1.6
   2.0
   2.0
   2.0
   Hct
   27.0
   23.5
   27.0
   24.5
   Plt
   121
   115
   118
   110
   Cr
   2.2
   2.4
   2.7
   3.0
   2.7
   2.6
   2.3
   TropT
   0.54
   Glucose
   106
   235
   135
   124
   102
   Other labs: PT / PTT / INR:15.3/28.3/1.3, CK / CKMB /
   Troponin-T:30/3/0.54, Ca++:8.6 mg/dL, Mg++:2.2 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   68 y.o. female with CAD s/p 4 vessel CABG and follow-up stent of
   LIMA-LAD c/b instent stenosis with restenting as well as severe CHF, EF
   of 20-30% who presents after recent discharge with acute on chronic
   renal failure.
   .
   # CORONARIES: s/p CABG with stent of LIMA to LAD.
   - continue ASA, statin, Plavix, low dose BB.
   .
   # PUMP: Known, severe CHF, s/p ICD. Currently thought to be total body
   fluid overloaded but pt tolerating well (lungs clear, satting well,
   comfortable), so switched to PO lasix to keep even to neg.
   .
   # RHYTHM: Episode of bradycardia in setting of CHB. Evaluated by EP and
   pacer settings changed
 no further episodes
   .
   # Acute on Chronic Renal Failure: Improving
   .
   # Asthma  - Continue Spiriva, albuterol, fluticasone
   .
   # Anemia/Myelodysplastic syndrome: At baseline
   - Transfuse as needed
   .
   # DM
   - Insulin SS w/ QID FS
   .
   # FEN   - Correct/Replete electrolytes PRN, no IVF, Diabetic/Cardiac
   diet
   # ACCESS: Right EJ
   # PROPHYLAXIS: SC Heparin, Bowel Regimen
   # CODE: FULL
   # CONTACT: HUSBAND [**Name (NI) 789**] [**Telephone/Fax (1) 6415**]  Daughter [**Name (NI) 129**] [**Telephone/Fax (1) 6602**]
   # DISPO: to floor today<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of the information and potential medical complications that can arise:

The patient is a 68-year-old female with a history of coronary artery disease (CAD) who underwent 4-vessel coronary artery bypass grafting (CABG) and had a follow-up stent placed in the left internal mammary artery (LIMA) to left anterior descending (LAD) artery. She also has severe chronic heart failure (CHF) with an estimated ejection fraction (EF) of 20-30%. The patient was recently discharged and presented with acute on chronic renal failure.

The patient's vital signs are stable, with a temperature of 98.5°C, heart rate of 79 bpm, blood pressure of 100/51 mmHg, and oxygen saturation of 98%. She is receiving heparin sodium for prophylaxis and has a right jugular venous access.

The patient's physical examination reveals no significant abnormalities, except for multiple areas of hyperpigmentation on her skin. Her laboratory results show elevated creatinine levels, with a peak value of 3.0 mg/dL, and anemia with a hemoglobin level of 8.1 g/dL.

The patient's medications include aspirin, statin, Plavix, low-dose beta blocker, and insulin, and she is also receiving PO lasix for fluid overload.

Potential medical complications that can arise include:

1. Acute kidney injury (AKI) due to acute on chronic renal failure, which can worsen the patient's overall condition and increase the risk of mortality.
2. Fluid overload, which can lead to respiratory distress, pulmonary edema, and cardiac failure.
3. Electrolyte imbalance, particularly hypokalemia, which can exacerbate cardiac arrhythmias and worsen CHF.
4. Anemia, which can further compromise the patient's cardiac function and increase the risk of bleeding.
5. Infection, particularly in the setting of chronic kidney disease, which can lead to sepsis and multi-organ failure.
6. Cardiac arrhythmias, particularly bradycardia, which can worsen CHF and increase the risk of cardiac arrest.
7. Bleeding complications, particularly in the setting of anticoagulation therapy, which can lead to hemorrhagic shock and multi-organ failure.

In conclusion, the patient's progress note suggests that she is at risk for several potential medical complications, including AKI, fluid overload, electrolyte imbalance, anemia, infection, cardiac arrhythmias, and bleeding complications. Close monitoring and prompt management of these complications are essential to prevent adverse outcomes and improve the patient's overall condition."
